文献速递认知障碍与谵妄老年综合评估

蒙特利尔认知评估量表诊断轻度认知障碍与痴呆的最佳短版本

The Optimal Short Version of Montreal Cognitive Assessment in Diagnosing Mild Cognitive Impairment and Dementia.
PubMed 文献 · J Am Med Dir Assoc · 2019-03-23

本研究基于美国阿尔茨海默病中心≥50岁参与者(n=4606)的队列基线数据,比较7种MoCA短版本与原始MoCA在识别轻度认知障碍或痴呆(MCI/痴呆)中的性能。结果显示仅Roalf等(2016)和Wong等(2015)两个短版本性能与原始MoCA相当,其中仅Roalf版本在较高教育程度亚组中仍与原始MoCA的AUC相似。

要点

  • 7种MoCA短版本辨别MCI/痴呆的AUC为87.7%-91.0%,均属可接受。
  • 仅Roalf和Wong两个短版本AUC(88.4-88.9%)与原始MoCA(89.3%)相当。
  • 较高教育程度者中仅Roalf版本AUC与原始MoCA相似,其他短版本受天花板效应限制。

核心结论

  • 不同MoCA短版本诊断性能并不一致,仅Roalf等(2016)版本在识别MCI或痴呆方面与原始MoCA相当,且在不同教育程度亚组中均表现相似。

研究设计与样本

  • 队列研究的基线数据分析,纳入美国阿尔茨海默病中心≥50岁参与者4606人,中位年龄70岁(四分位距65-76岁)。

主要发现

  • 所有7种MoCA短版本区分MCI/痴呆与正常认知的AUC为87.7%-91.0%。
  • 仅Roalf等(2016)和Wong等(2015)两个短版本AUC(88.4-88.9%)与原始MoCA(89.3%)相当。
  • 在较高教育程度参与者中,仅Roalf等版本AUC与原始MoCA相似,其他短版本受天花板效应限制。
  • 原始MoCA在最佳截断值<25时灵敏度84.4%、特异度76.4%;Roalf等版本在最佳截断值<13时灵敏度87.2%、特异度72.1%。

关键数值与推荐

  • 原始MoCA最佳截断值<25:灵敏度84.4%,特异度76.4%。
  • Roalf等短版本最佳截断值<13:灵敏度87.2%,特异度72.1%。
  • Roalf等短版本长度为原始MoCA的三分之一,完成时间<5分钟。

临床怎么用

  • 当临床实践中无法实施原始MoCA时,Roalf等短版本可作为可行替代,尤其适用于认知障碍高风险患者量大且非专科的门诊(如基层医疗、老年科和卒中预防门诊)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: While various short variants of the Montreal Cognitive Assessment (MoCA) have been developed, they have not been compared among each other to determine the most optimal variant for routine use. This study evaluated the comparative performance of the short variants in identifying mild cognitive impairment or dementia (MCI/dementia). DESIGN: Baseline data of a cohort study. SETTING: Alzheimer's Disease Centers across the United States. PARTICIPANTS: Participants aged ≥50 years (n = 4606), with median age 70 (interquartile range 65-76). MEASURES: Participants completed MoCA and were evaluated for MCI/dementia. The various short variants of MoCA were compared in their performance in discriminating MCI/dementia, using areas under the receiver operating characteristic curve (AUCs). RESULTS: All 7 short variants of MoCA had acceptable performance in discriminating MCI/dementia from normal cognition (AUC 87.7%-91.0%). However, only 2 variants by Roalf et al (2016) and Wong et al (2015) demonstrated comparable performance (AUC 88.4-88.9%) to the original MoCA (AUC 89.3%). Among the participants with higher education, only the variant by Roalf et al had similar AUC to the original MoCA. At the optimal cut-off score of <25, the original MoCA demonstrated 84.4% sensitivity and 76.4% specificity. In contrast, the short variant by Roalf et al had 87.2% sensitivity and 72.1% specificity at its optimal cut-off score of <13. CONCLUSIONS/IMPLICATIONS: The various short variants may not share similar diagnostic performance, with many limited by ceiling effects among participants with higher education. Only the short variant by Roalf et al was comparable to the original MoCA in identifying MCI or dementia even across education subgroups. This variant is one-third the length of the original MoCA and can be completed in <5 minutes. It provides a viable alternative when it is not feasible to administer the original MoCA in clinical practice and can be especially useful in nonspecialty clinics with large volumes of patients at high risk of cognitive impairment (such as those in primary care, geriatric, and stroke prevention clinics).

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Liew TM. The Optimal Short Version of Montreal Cognitive Assessment in Diagnosing Mild Cognitive Impairment and Dementia. J Am Med Dir Assoc. 2019. PMID: 30910550. doi:10.1016/j.jamda.2019.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。